Literature DB >> 4357222

Effect of propranolol on cyclic AMP excretion and plasma renin activity in labile essentrial hypertension.

P Hamet, O Kuchel, J L Cuche, R Boucher, J Genest.   

Abstract

Labile hypertension is often associated with elevated cardiac output, increased plasma renin activity (PRA) and urinary cyclic AMP excretion in response to upright posture and to isoproterenol. The beta-blocking agent propranolol was demonstrated to be an effective therapeutic agent in this condition. The effect of posture on cyclic AMP, PRA, pulse rate and blood pressure was therefore studied during the administration of propranolol and a placebo in patients with labile hypertension. With the patient on placebo, upright posture induced an increase in pulse rate, cyclic AMP excretion and PRA. Propranolol administration decreased the recumbent and upright blood pressures, pulse rate and PRA. Cyclic AMP excretion remained unchanged in the recumbent position but the postural increase was abolished. No appreciable changes in catecholamine excretion occurred during propranolol administration. Propranolol normalizes some humoral as well as hemodynamic abnormalities of labile hypertension and therefore may be of benefit in long-term treatment and possibly also in the prevention of stable hypertension.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4357222      PMCID: PMC1947200     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  27 in total

1.  THE INNERVATION OF THE JUXTAGLOMERULAR APPARATUS. AN ELECTRON MICROSCOPIC STUDY OF THE INNERVATION OF THE GLOMERULAR ARTERIOLES.

Authors:  L BARAJAS
Journal:  Lab Invest       Date:  1964-08       Impact factor: 5.662

2.  Changes of cardiac output in hypertensive disease.

Authors:  J WIDIMSKY; M H FEJFAROVA; Z FEJFAR
Journal:  Cardiologia       Date:  1957

3.  Effect of upright posture and isoproterenol infusion on cyclic adenosine monophosphate excretion in control subjects and patients with labile hypertension.

Authors:  P Hamet; O Kuchel; J Genest
Journal:  J Clin Endocrinol Metab       Date:  1973-02       Impact factor: 5.958

4.  [Beta adrenergic receptors as mediators of renin release].

Authors:  K A Meurer; H M Dieter; D Schmid; H J Schmidt; W Kaufmann
Journal:  Dtsch Med Wochenschr       Date:  1971-04-23       Impact factor: 0.628

5.  Hemodynamic responses to tilt and beta-adrenergic blockade in young patients with borderline hypertension.

Authors:  R Sannerstedt; S Julius; J Conway
Journal:  Circulation       Date:  1970-12       Impact factor: 29.690

6.  Effects of cyclic AMP, sympathomimetic amines, and adrenergic receptor antagonists on renin secretion.

Authors:  N Winer; D S Chokshi; W G Walkenhorst
Journal:  Circ Res       Date:  1971-09       Impact factor: 17.367

7.  Beta adrenergic blocking properties of D and DL propränolol in man.

Authors:  I Brick; K J Hutchinson; I C Roddie
Journal:  Ir J Med Sci       Date:  1970-03       Impact factor: 1.568

Review 8.  Adenyl cyclase as an adrenergic receptor.

Authors:  G A Robison; R W Butcher; E W Sutherland
Journal:  Ann N Y Acad Sci       Date:  1967-02-10       Impact factor: 5.691

9.  Hyperdynamic beta-adrenergic circulatory state.

Authors:  E D Frohlich; H P Dustan; I H Page
Journal:  Arch Intern Med       Date:  1966-05

10.  Effects of parathyroid hormone on plasma and urinary adenosine 3',5'-monophosphate in man.

Authors:  N I Kaminsky; A E Broadus; J G Hardman; D J Jones; J H Ball; E W Sutherland; G W Liddle
Journal:  J Clin Invest       Date:  1970-12       Impact factor: 14.808

View more
  4 in total

1.  Decrease in plasma noradrenaline levels following long-term treatment with prindolol in patients with essential hypertension.

Authors:  H M Brecht; F Banthien; W Schoeppe
Journal:  Klin Wochenschr       Date:  1976-11-15

2.  Long term treatment of moderate hypertension with penbutolol (Hoe 893d). I. Effects on blood pressure, pulse rate, catecholamines in blood and urine, plasma renin activity and urinary aldosterone under basal conditions and following exercise.

Authors:  B G Hansson; B Hökfelt
Journal:  Eur J Clin Pharmacol       Date:  1975-10-10       Impact factor: 2.953

3.  [Cyclic AMP and plasma renin activity in renal vein blood after amitryptiline, theophylline, furosemide and beta adrenergic blocking substances (author's transl)].

Authors:  J Zehner; D Klaus; F Klumpp; R Lemke
Journal:  Klin Wochenschr       Date:  1976-11-15

4.  Plasma adenosine 3',5'-cyclic monophosphate in human hypertension.

Authors:  P Hamet; O Kuchel; J Fraysse; J Genest
Journal:  Can Med Assoc J       Date:  1974-08-17       Impact factor: 8.262

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.